KETALAR 50 MG
KETAMINE (KETAMINE HYDROCHLORIDE) : 50 MG · DIN 00224405 · SEARCHLIGHT PHARMA INC
Health Canada status: MARKETED
What is KETALAR?
KETALAR 50 MG contains KETAMINE (KETAMINE HYDROCHLORIDE) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 00224405, held by SEARCHLIGHT PHARMA INC, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 12-Feb-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is KETALAR used for?
Sole anesthetic for short diagnostic/surgical procedures; induction of anesthesia; supplement to low potency agents like nitrous oxide.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is KETALAR called?
The same molecule, KETAMINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Micro-Ketamine | Latin | South Africa |
| Tekam | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 00224405 |
|---|---|
| Brand name | KETALAR |
| Generic / active ingredient | KETAMINE (KETAMINE HYDROCHLORIDE) : 50 MG |
| Manufacturer | SEARCHLIGHT PHARMA INC |
| Strength | 50 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N01AX03 KETAMINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 12-Feb-2024 |
| Original market date | 1971-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 00224405 |
|---|---|
| DIN (unpadded, as printed on some documents) | 224405 |
| Brand name | KETALAR |
| Active ingredient / INN | KETAMINE (KETAMINE HYDROCHLORIDE) : 50 MG |
| ATC code | N01AX03 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N01 |
| Health Canada schedule | NARCOTICS (CDSA I) |
| Biosimilar biologic | No |
| Market authorization holder | SEARCHLIGHT PHARMA INC |
How is it administered?
Induction: 1-4.5 mg/kg IV (slowly over 60s) or 6.5-13 mg/kg IM. Maintenance: increments of 1/2 to full induction dose as needed. Titrate to patient requirements.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store in original container at room temperature (15°C to 30°C). Protect from light. Discard unused product after operating session.
How is it supplied?
10 mL vials (500 mg) and 20 mL vials (200 mg).
Which pack is which?
| Strength on the label | 50 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR ; INTRAVENOUS |
| Packaging as described in the monograph | 10 mL vials (500 mg) and 20 mL vials (200 mg). |
| Storage | Store in original container at room temperature (15°C to 30°C). Protect from light. Discard unused product after operating session. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Contraindications
History of CVA; significant hypertension; severe cardiac decompensation; surgery of pharynx/larynx/bronchial tree without muscle relaxants; hypersensitivity to ketamine.
Warnings and precautions
Use only by experienced physicians. Monitor cardiac function. Risk of liver enzyme elevation/fibrosis with chronic use. Increased CSF pressure risk. Potential for drug abuse/dependence.
Is KETAMINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANDOZ CANADA INCORPORATED, last seen 05 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N01AX03 KETAMINE. 7 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KETALAR | 10 MG | SOLUTION | SEARCHLIGHT PHARMA INC | MARKETED | DIN 00224391 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02246795 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02246796 |
| KETAMINE HYDROCHLORIDE INJECTION, USP | 10 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02550431 |
| KETAMINE HYDROCHLORIDE INJECTION, USP | 50 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02550458 |
| KETAMINE INJECTION, BP | 50 MG | SOLUTION | STERIMAX INC | MARKETED | DIN 02535645 |
| KETAMINE HYDROCHLORIDE INJECTION SDZ | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02387301 |
| KETAMINE HYDROCHLORIDE INJECTION SDZ | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02387336 |
| KETAMINE HYDROCHLORIDE INJECTION SDZ | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02387328 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 100 MG / 2 ML | SOLUTION | STERIMAX INC | APPROVED | DIN 02470934 |
How much does KETAMINE cost around the world?
KETAMINE is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Saudi Arabia publishes a public; South Africa publishes a single exit price; United Kingdom publishes a hospital. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 2 | 12 | USD███.██ |
| South Africa | single exit price | 4 | 6 | ZAR███.██ |
| Saudi Arabia | public | 3 | 4 | SAR███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
24 pack listings across 11 brand entries and 4 price bases, refreshed 03 Sep 2026. Ranges span every KETAMINE pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.